Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oazvita Biotech is a drug discovery and development company focused on creating novel small molecule therapeutics for unmet medical needs in oncology, metabolic disorders, and inflammatory diseases. Based in Hyderabad, India, the company utilizes its proprietary discovery platform to identify and optimize New Chemical Entities (NCEs). Oazvita aims to bridge the gap between early-stage research and clinical development through strategic partnerships and internal R&D. Their portfolio includes several programs in the lead optimization and pre-clinical stages, with a particular focus on targeted protein degradation and kinase inhibition. The company leverages advanced computational tools and structure-based drug design to accelerate the development of high-potency candidates. By combining deep biological insights with medicinal chemistry expertise, Oazvita seeks to deliver transformative medicines to patients globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oazvita Biotech.